Discover 318 paid clinical trials in Mississippi. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Mississippi provides diverse clinical research opportunities, opening doors for healthy volunteers interested in paid studies, as well as people with specific health conditions to contribute to medical research. Research hubs in Jackson, Gulfport, and Hattiesburg are actively recruiting, granting participants access to innovative treatments and comprehensive care.
Filter
1
Filter results
Results: 318
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
for
Peripheral Vascular Diseases
Location: Boston MA, Providence RI, New Haven CT, New York NY,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT04674969
Recruiting
Prostate Artery Embolization: Single Center Experience
for
Benign Prostatic Hyperplasia (BPH),
Location: Jackson MS
Sponsor: University of Mississippi Medical Center
Sex: Male
Age: 45+
Code: NCT04766268
Recruiting
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
for
Ischemic Stroke, Intracerebral Hemorrhage,
Location: Boston MA, The Bronx NY, New York NY, Philadelphia PA,
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT04916210
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
for
Non-Small Cell Lung Cancer
Location: Milford MA, Weymouth MA, Brighton MA, Boston MA,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT06767514
Phase3, Recruiting
Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial
for
Sepsis, Acute Infection, Organ Failure
Location: Jackson MS, Iowa City IA, Maplewood MN, Minneapolis MN,
Sponsor: University of Minnesota
Sex: All
Age: 65+
Code: NCT05758246
Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
for
Non-small Cell Lung Cancer
Location: New York NY, Lancaster PA, Greenville NC, Syracuse NY,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT06561386
Phase3, Recruiting
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma